De Giglio A.; Di Federico A.; Metro G., Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer, «TRANSLATIONAL LUNG CANCER RESEARCH», 2022, 11, pp. 1734 - 1738 [articolo]
Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; De Biase, Dario; Giunchi, Francesca; Palladini, Arianna; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea, Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes, «CANCERS», 2022, 14, Article number: 3472, pp. 1 - 15 [articolo]Open Access
Andrini E.; Di Federico A.; Sisi M.; Rosellini M.; Palladini A.; Lamberti G.; De Giglio A.; Gelsomino F., Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies, «IMMUNOTHERAPY», 2022, 14, pp. 1329 - 1340 [articolo]
Di Federico A.; Mosca M.; Pagani R.; Carloni R.; Frega G.; De Giglio A.; Rizzo A.; Ricci D.; Tavolari S.; Di Marco M.; Palloni A.; Brandi G., Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes, «CANCERS», 2022, 14, Article number: 2429, pp. 1 - 14 [articolo]Open Access
Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi., Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumour Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes, «CANCERS», 2022, 14, Article number: 2429, pp. 1 - 14 [articolo]Open Access
De Giglio, Andrea; Aprile, Marta; Di Federico, Alessandro; Sperandi, Francesca; Melotti, Barbara; Gelsomino, Francesco; Ardizzoni, Andrea, Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC), «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2022, 23, pp. 10292 - 10299 [articolo]Open Access
Rizzo A.; Dadduzio V.; Ricci A.D.; Massari F.; Di Federico A.; Gadaleta-Caldarola G.; Brandi G., Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2022, 31, pp. 371 - 378 [articolo]
Rizzo, Alessandro; Carloni, Riccardo; Ricci, Angela Dalia; Di Federico, Alessandro; Guven, Deniz Can; Yalcin, Suayib; Brandi, Giovanni, Molecular Profile and Prognostic Value of BAP1 Mutations in Intrahepatic Cholangiocarcinoma: A Genomic Database Analysis, «JOURNAL OF PERSONALIZED MEDICINE», 2022, 12, Article number: 1247, pp. . - . [articolo]
Rossi, Simone; Merli, Elena; Rinaldi, Rita; Deleonardi, Gaia; Mastrangelo, Vincenzo; Sasdelli, Anna Simona; Di Federico, Alessandro; Guarino, Maria; Donadio, Vincenzo; Pironi, Loris; Gelsomino, Francesco; De Giorgio, Roberto; D'Angelo, Roberto, Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review, «JOURNAL OF NEUROLOGY», 2022, 269, pp. 1182 - 1194 [articolo]
De Giglio, Andrea; Grandinetti, Valeria; Aprile, Marta; Borelli, Greta; Campus, Anita; Croci Chiocchini, Anna Laura; Busutti, Marco; Vischini, Gisella; Di Federico, Alessandro; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea; La Manna, Gaetano; Gelsomino, Francesco, Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience, «LUNG CANCER», 2022, 174, pp. 91 - 96 [articolo]
Rizzo, Alessandro; Salati, Massimiliano; Frega, Giorgio; Merz, Valeria; Caputo, Francesco; Di Federico, Alessandro; Palloni, Andrea; Carloni, Riccardo; Ricci, Angela Dalia; Gadaleta-Caldarola, Gennaro; Messina, Carlo; Spallanzani, Andrea; Gelsomino, Fabio; Benatti, Stefania; Luppi, Gabriele; Melisi, Davide; Dominici, Massimo; Brandi, Giovanni, Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study, «MEDICINA», 2022, 58, Article number: 1543, pp. . - . [articolo]
De Giglio, Andrea; Tassinari, Elisa; Zappi, Arianna; Di Federico, Alessandro; Lenzi, Barbara; Sperandi, Francesca; Melotti, Barbara; Gelsomino, Francesco; Maltoni, Marco; Ardizzoni, Andrea, The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with Immunotherapy, «CANCERS», 2022, 14, pp. 5845 - 5851 [articolo]Open Access
Brandi G.; Di Federico A.; Rizzo A.; De Lorenzo S.; Vasuri F.; Brocchi S.; Golfieri R.; Morelli M.C.; Frega G.; Palloni A., The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma, «ANTI-CANCER DRUGS», 2022, 33, pp. e781 - e783 [articolo]
Di Federico A.; Filippini D.M.; Sperandi F.; Ardizzoni A.; Melotti B., Acute kidney injury as a possible immune-related adverse event associated with sustained complete response to BRAF and MEK inhibitors in advanced, V600E-mutated melanoma, «EUROPEAN JOURNAL OF CANCER», 2021, 147, pp. 58 - 59 [articolo]
Filippini D.M.; Di Federico A.; Lenzi B.; Nobili E.; Brocchi S.; Malvi D.; Brandi G., Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report, «ANNALS OF PALLIATIVE MEDICINE», 2021, 10, pp. 8474 - 8478 [articolo]Open Access
